
Xenofer50 mg/2.5
Beacon Pharmaceuticals PLC
Iron Sucrose Injection [Elemental Iron] is a parenteral (intravenous) iron replacement product used to treat iron-deficiency anemia in patients for whom oral iron is inadequate, not tolerated and more.
Iron Sucrose Injection [Elemental Iron] is a parenteral (intravenous) iron replacement product used to treat iron-deficiency anemia in patients for whom oral iron is inadequate, not tolerated, or clinically inappropriate.
Iron Sucrose Injection [Elemental Iron] is not indicated for anemias not caused by iron deficiency (e.g. hemolytic anemia, anemia of chronic disease without proven iron deficiency).
Iron Sucrose Injection [Elemental Iron] is dosed according to the calculated iron deficit and clinical indication, and is administered only by intravenous injection or infusion by a trained healthcare professional. It must never be given intramuscularly or self-administered by the patient at home.
| Population | Typical Dose | Notes |
|---|---|---|
| Hemodialysis-dependent CKD | 100 mg by slow IV injection or infusion | Given repeatedly per dialysis session, per individualized treatment course |
| Non-dialysis-dependent CKD | 200 mg by slow IV injection or infusion | Given on 5 occasions within a 14-day period per treatment course |
| Peritoneal dialysis-dependent CKD | 300 mg then 400 mg by infusion, then 400 mg | Administered over a 28-day treatment course |
Local prescribing practice in Bangladesh commonly describes adult dosing as 100–200 mg elemental iron, given one to three times weekly depending on hemoglobin level and calculated iron deficit, up to a maximum of 200 mg per single injection — this should be individualized by the treating physician based on the calculated total iron deficit.
In children 2 years of age and older with CKD-associated iron-deficiency anemia, the recommended dose is 0.5 mg/kg by slow IV injection or infusion, repeated as needed, not to exceed 100 mg per dose. Safety and efficacy in children under 2 years have not been established.
No specific dose adjustment beyond the indication-based dosing above is well established for renal or hepatic impairment; Iron Sucrose Injection [Elemental Iron] is in fact the treatment for iron deficiency that commonly accompanies chronic kidney disease, and dosing already accounts for renal status per the schedules above. Use with caution in significant hepatic impairment, with close monitoring for iron overload.
Total cumulative dose should be calculated individually (e.g. using a body-weight/hemoglobin-deficit formula) and should not be exceeded, to avoid iron overload. See Contraindications and Precautions and Warnings.
Adverse effects associated with Iron Sucrose Injection [Elemental Iron] range from common, mild infusion-related symptoms to rare but serious hypersensitivity reactions.
Patients should seek immediate medical attention for symptoms such as difficulty breathing, swelling of the face/throat, rash, or fainting.
Iron Sucrose Injection [Elemental Iron] is contraindicated in patients with:
Conditions such as active infection or a history of drug allergies are important cautions requiring careful clinical judgment, but are not absolute contraindications — see Precautions and Warnings.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.